Following recent breakthroughs, led by Allogene Therapeutics and Sana Biotechnology, it’s evident that 2025 is going to be a year marked by allogeneic innovation and clinical success.
This week, pharmaphorum heads to the Big Apple for the FT US Pharma and Biotech Summit, a one-day event where executives from some of the world’s top pharma companies will come together to
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.